Home Synthesis, structure and in vitro cytotoxic activity of two organotin complexes of 2-phenyl-1,2, 3-triazole-4-carboxylic acid
Article Open Access

Synthesis, structure and in vitro cytotoxic activity of two organotin complexes of 2-phenyl-1,2, 3-triazole-4-carboxylic acid

  • Laijin Tian EMAIL logo , Lingdong Kong and Changfa Zhang
Published/Copyright: August 8, 2015

Abstract

Two organotin complexes of 2-phenyl-1,2, 3-triazole-4-carboxylic acid, {[n-Bu2Sn(OOCC2HN3Ph-2)]2O}2 (1) and (c-C6H11)3Sn(OOCC2HN3Ph-2)(C2H5OH) (2), have been synthesized and characterized by means of elemental analysis, FT-IR, NMR (1H, 13C and 119Sn) spectra and X-ray single crystal diffraction. Compound 1 is a centrosymmetric tetranuclear bis(dicarboxylatotetra-n-butyldistannoxane) complex containing two distinct types of carboxylate moieties and tin atoms with [SnC2O3] trigonal-bipyramidal and [SnC2O4] skew-trapezoidal-bipyramidal geometries. Compound 2 possesses a [SnC3O2] trigonal bipyramidal environment with the axial positions occupied by the carboxylate oxygen and hydroxyl oxygen of an ethanol molecule and forms a one-dimensional supramolecular structure by intermolecular O-H···O hydrogen bonds. Bioassay results have shown that the two compounds possess good in vitro cytotoxic activity against three human tumor cell lines (HeLa, CoLo205 and MCF-7).

Introduction

In recent years, organotin carboxylates have received considerable attention due to their structural interest and various applications (Tiekink, 1991, 1994; Davies et al., 2008). Many researchers have described the preparation and characterization of organotin carboxylates and their activity against tumors, fungi, bacteria and other microorganisms (Shang et al., 2011; Seter et al., 2012; Kaur et al., 2013; Nath et al., 2013, 2014; Dong et al., 2014; Wang et al., 2014; Mao et al., 2015). It has been observed that some di- and triorganotin carboxylates show potential as antineoplastic agents (Hadjikakou and Hadjiliadis, 2009; Amir et al., 2014; Carraher and Roner, 2014). The number and nature of the organic groups bonded to the tin center and the carboxylate ligand appear to play an important role in determining their antitumor activity (Hadjikakou and Hadjiliadis, 2009; Amir et al., 2014). The design and synthesis of new organotin carboxylates by selecting ligands and organotin substrates has been encouraged in order to achieve efficacy. 2-Phenyl-1,2,3-triazole-4-carboxylic acid is an acid containing an N-donor aromatic heterocycle, and we previously reported the synthesis and biological activity of several of its triorganotin complexes (Tian et al., 2005). In order to continue to expand the chemistry and therapeutic potential of the organotin esters of 2-phenyl-1,2, 3-triazole-4-carboxylic acid, we synthesized two new organotin complexes of this acid, {[n-Bu2Sn(OOCC2HN3 Ph-2)]2O}2 and (c-C6H11)3Sn(OOCC2HN3Ph-2)(C2H5OH), and determined their in vitro cytotoxic activity.

Results and discussion

Synthesis

Compound 1 was prepared by azeotropic removal of water from the reaction between di-n-butyltin oxide and 2-phenyl 1,2,3-triazole-4-carboxylic acid in the molar ratio 1:1 in toluene (Scheme 1).

Scheme 1: Synthesis of compound 1.
Scheme 1:

Synthesis of compound 1.

Compound 2 was synthesized in ethanol by the reaction of tricyclohexyltin chloride with 2-phenyl 1,2,3-triazole-4-carboxylic acid in the presence of Et3N (Scheme 2).

Scheme 2: Synthesis of compound 2.
Scheme 2:

Synthesis of compound 2.

When the reaction of di-n-butyltin oxide with the ligand acid is performed in the molar ratio 1:2 in toluene, the product n-Bu2Sn(OOCC2HN3Ph-2)2 (3) should be formed. We tried to isolate and purify compound 3, but failed. Compound 2 is an ethanol solvate of (cyclo-C6H11)3 Sn(OOCC2HN3Ph-2) (4) that had been obtained previously by the reaction of tricyclohexyltin hydroxide with 2-phenyl 1,2,3-triazole-4-carboxylic acid in benzene (Tian et al., 2005), and converted readily into 4 when heated at 80°C for 1 h or dried in vacuum for 48 h at room temperature. Both compounds 1 and 2 are white solids and soluble in benzene and in common polar organic solvents such as methanol, ethanol, trichloromethane, acetone and N,N-dimethylformamide.

Spectroscopic analysis

In the complexes, the strong band at ~1600 cm-1 assigned to the stretching vibration of C=N of the triazole ring was almost the same as that of the free 2-phenyl-1,2,3-triazole-4-carboxylic acid, indicating that the N atom of the triazole ring was not coordinated to the tin atom. In organotin carboxylates, IR spectroscopy can provide useful information concerning the coordination mode of the carboxylate group (Deacon and Phillips, 1980; Szorcsik et al., 2004). When the carboxylic group of the ligand coordinates to the metal in the monodentate mode, the difference between the νas(COO) and νs(COO) bands, Δν(COO), is larger than that observed for ionic compounds. When the ligand chelates, Δν is smaller than that observed for its ionic compounds, whereas for the asymmetric bidentate coordination, the value is in the range characteristic of monodentate coordination. When the carboxylate group bridges metal ions, the Δν value is higher than that of the chelated ions and nearly the same as that observed for ionic compounds. In 1, the Δν(COO) value is 284 and 199 cm-1, respectively. The former is larger than that of the sodium salt of the free acid (Δν=208 cm-1), and the latter is less than the Δν value of the sodium salt, which indicate that there are monodentate carboxylate and weak chelating/ bridging bidentate carboxylate groups (see below X-ray crystallography) (Deacon and Phillips, 1980; Chandrasekhar et al., 1988). A strong band of 640 cm-1 is assigned to vibration associated with the Sn-O-Sn stretch (Chandrasekhar et al., 1988). In 2, a broad band at 3446 cm-1 was assigned to the ν(OH) mode of ethanol. The magnitude (241 cm-1) of Δν(COO) confirms that the carboxylate group is monodentate coordination to tin, which is in agreement with the solid-state structure shown below.

The 1H NMR spectra show the expected integration and peak multiplicities. Two resonances were observed for the butyl protons and carbon atoms in compound 1, which is consistent with the presence of a dimer in solution by analogy with related compounds (Baul et al., 2006). This indicates that two types of tin centers are present with non-equivalent surroundings. This was further confirmed by the crystal structure of compound 1. Although two structurally different carboxylate groups are present in 1, as revealed by the crystal structure analyses (see below), only a single broad resonance (δ 165.3 ppm) is observed for the C(O)O carbon atoms in the 13C NMR spectrum, which might also correspond to the situation when two 13C resonances from two distinct carboxyl groups exist, but the difference between them is rather small in the CDCl3 solution. This could arise in the case of fast intramolecular rearrangement on the NMR time scale, as described by Martins et al. (Martins et al., 2000; Baul et al., 2006). In compound 2, the cyclohexyl protons show the multiplet in the range 1.31–2.07 ppm. The resonance signals of cyclohexyl carbon atoms appear at 27.2, 29.2, 31.4 and 34.1 ppm, respectively, and the spin-spin coupling constants 1J(119Sn-13C) and 3J(119Sn-13C) are 330 and 65 Hz, respectively. The coordination number of the tin atom in organotin compounds has been related to the 1J(119Sn-13C) coupling constants (Holecek et al., 1983). The 1J(119Sn-13C) value in 2 is close to that of the corresponding four-coordinate tricyclohexyltin carboxylates, such as 2-HOC6H4N=NC6H4COOSn(cyclo-C6H11)3 (1J(119Sn-13C)=335 Hz) (Willem et al., 1998), (cyclo-C6H11)3SnOOCCH2CH2COOSn(c-C6H11)3 (1J(119Sn-13C)= 340 Hz) (Tian et al., 2013) and (cyclo-C6H11)3SnOOCCH2CH2COCH2CH2COOSn(cyclo-C6H11)3 (1J(119Sn-13C)=325 Hz) (Chalupa et al., 2006), suggesting that ethanol is free and the tin atom is four-coordinated in the CDCl3 solution.

The 119Sn chemical shifts primarily depend on the coordination number and the nature of the donor atom directly bonded to the central tin atom (Davis, 2004). In CDCl3, the 119Sn NMR spectra of compound 1 display two 119Sn resonances of -194.0 and -205.2 ppm, which are assigned to the endocyclic and exocyclic tin atoms, respectively. Holecek et al. (1986) reported that the four-coordinate di-n-butyltin compounds have δ(119Sn) ranging from about +200 to -60 ppm; five-coordinate compounds, -90 to -190 ppm; and six-coordinate compounds, -210 to -400 ppm. Based on the results, five-coordinated endocyclic tin centers and near six-coordinated exocyclic tin centers are present in the CDCl3 solution, which is consistent with the X-ray crystal structure of 1 (below). The 119Sn chemical shift of 2 (17.6 ppm) in CDCl3 is in accord with the value found in (cyclo-C6H11)3Sn(OOCC2HN3Ph-2) (18.7 ppm) (Tian et al., 2005) and other four-coordinated tricyclohexyltin compounds in solution of non-coordinating solvent (Willem et al., 1998; Chalupa et al., 2006), confirming that the tin atom is four-coordinated in the CDCl3 solution. However, in dimethylsulfoxide-d6 (DMSO-d6), the 119Sn chemical shifts appear at -89.6 ppm, which shows that the coordination of the solvent through the oxygen atom to the Sn atom and the tin atom may be five-coordinated (Nadvornik et al., 1984).

Structure analysis of compounds 1 and 2

The structures in the solid state of complexes 1 and 2 are shown in Figures 13 and the selected geometric parameters are given in Table 1. Compound 1 crystallizes in the triclinic space group P-1 and possesses the basic type II structural motif described by Tiekink (1991) (Scheme 3). Compound 1 is a centrosymmetric tetranuclear dimer built up around the planar cyclic Sn2O2 core in which the two oxygen atoms [O(5) and O(5A), symmetry code A: -x+1, -y+2, -z+1] are tridentate as they link three tin centers – two endocyclic and one exocyclic. The distance between the endocyclic and exocyclic tin atoms is 3.521(1) Å and the distance between the two endocyclic tin centers is 3.325(1) Å. Additional links between the endocyclic and exocyclic tin atoms are provided by the carboxylate O-atoms in an asymmetric μ2-oxo fashion. The distances of two Sn-O bonds, Sn(1)-O(3) and Sn(2)-O(3), are 2.243(4) and 2.422(4) Å, respectively. The exocyclic Sn(1) atom in 1 is six-coordinated, and the six coordination atoms come from two carbon atoms C(19) and C(23) of n-butyl groups, one μ3-O(5) atom, one μ2-O(3) atom of one carboxylate and two oxygen atoms O(1) and O(2) of the other carboxylate. Because the two O atoms of carboxylate C(1)O(1)O(2) coordinate, in an asymmetric fashion, to Sn(1) with the longer Sn(1)-O(2) interaction of 2.675(4) Å and the smaller bite angle O(1)-Sn(1)-O(2) of 53.18(13)°, the environment of the Sn(1) atom may be described as a distorted skew-trapezoidal bipyramid with the n-butyl ligands occupying axial positions [C(19)-Sn(1)-C(23) 142.1(2)°]. The Sn(1)···N(4) separation (3.134(2) Å) was smaller than the sum of Van der Waals radii of tin and nitrogen (3.74 Å) (Bondi, 1964), indicating that there was a weak interaction between N(4) and Sn(1). Thus, the N(4) atom also exerted a steric influence and contributed to the distortion of the geometry at the Sn(1) atom. The endocyclic Sn(2) atoms have five-coordination, and the coordination atoms are C(27) and C(31) from two n-butyl groups, μ3-O(5) and μ3-O(5A) atoms, and the μ2-O(3) atom of the carboxylate, respectively. The coordination geometry of Sn(2) is a quite distorted trigonal bipyramidal with axial positions occupied by oxygen atoms [O(3)-Sn(1)-O(5A) 147.40(13)°]. The Sn(2) atom lies 0.071(1) Å out of the trigonal plane defined by O(5), C(27) and C(31) in the direction of the atom O(5A). The Sn(2)···O(4) and Sn(2)···O(1A) separations of 3.364(2) and 3.331(2) Å are shorter than the sum of the Van der Waals radii of tin and oxygen (3.73 Å) and much longer than the sum of the covalent radii of tin and oxygen (2.14 Å) (Bondi, 1964), which was not indicative of a significant interaction between these atoms. The major stereochemical role of the O(4) and O(1A) atoms is to distort the bipyramidal geometry by opening up the C(27)-Sn(2)-C(31) angle to 127.9(4)°. In bis(dicarboxylatotetraorganodistannoxanes), {[R2Sn(OOCR′)]2O}2, the type II structural motif displayed by compound 1 occurs less frequently than the more common type I motif (Tiekink, 1991; Chandrasekhar et al., 2002). The structural feature of 1 is similar to that of several reported bis(dicarboxylatotetraorganodistannoxanes) possessing the type II motif (Table 2).

Figure 1: The molecular structure of compound 1. All hydrogen atoms and partial carbons of butyl bond to Sn atoms are omitted for clarity.
Figure 1:

The molecular structure of compound 1. All hydrogen atoms and partial carbons of butyl bond to Sn atoms are omitted for clarity.

Figure 2: The molecular structure of compound 2. All hydrogen atoms are omitted for clarity.
Figure 2:

The molecular structure of compound 2. All hydrogen atoms are omitted for clarity.

Table 1

Selected bond lengths (Å) and angles (°) for 1 and 2.

1
Sn(1)-O(1)2.155(4)Sn(1)-C(23)2.131(5)Sn(2)-C(31)2.122(8)
Sn(1)-O(2)2.675(4)Sn(2)-O(3)2.243(4)C(1)-O(1)1.291(7)
Sn(1)-O(3)2.422(4)Sn(2)-O(5)2.036(3)C(1)-O(2)1.220(7)
Sn(1)-O(5)2.032(3)Sn(2)-O(5A)2.140(3)C(10)-O(3)1.305(7)
Sn(1)-C(19)2.110(6)Sn(2)-C(27)2.115(6)C(10)-O(4)1.218(7)
O(5)-Sn(1)-C(19)107.6(2)O(1)-Sn(1)-O(3)152.19(13)C(27)-Sn(2)-C(31)127.9(4)
O(5)-Sn(1)-C(23)106.6(2)O(5)-Sn(1)-O(2)136.14(14)O(5)-Sn(2)-O(5A)74.50(15)
C(19)-Sn(1)-C(23)142.1(2)C(19)-Sn(1)-O(2)84.2(2)C(27)-Sn(2)-O(5A)100.18(19)
O(5)-Sn(1)-O(1)83.01(13)C(23)-Sn(1)-O(2)82.6(2)C(31)-Sn(2)-O(5A)98.7(3)
C(19)-Sn(1)-O(1)99.5(2)O(1)-Sn(1)-O(2)53.18(13)O(5)-Sn(2)-O(3)72.95(13)
C(23)-Sn(1)-O(1)100.5(2)O(3)-Sn(1)-O(2)154.61(13)C(27)-Sn(2)-O(3)92.59(19)
O(5)-Sn(1)-O(3)69.18(13)O(5)-Sn(2)-C(27)116.4(2)C(31)-Sn(2)-O(3)96.7(3)
C(19)-Sn(1)-O(3)89.12(19)O(5)-Sn(2)-C(31)115.4(3)O(5A)-Sn(2)-O(3)147.40(13)
C(23)-Sn(1)-O(3)87.94(19)
2
Sn(1)-C(1)2.152(4)Sn(1)-O(1)2.161(3)C(20)-N(3)1.325(4)
Sn(1)-C(7)2.167(4)Sn(1)-O(3)2.518(3)C(19)-O(1)1.280(4)
Sn(1)-C(13)2.145(4)C(21)-N(1)1.329(5)C(19)-O(2)1.219(4)
C(13)-Sn(1)-C(1)122.22(17)C(1)-Sn(1)-C(7)121.35(16)C(1)-Sn(1)-O(3)82.36(13)
C(13)-Sn(1)-O(1)88.14(14)O(1)-Sn(1)-C(7)104.53(14)O(1)-Sn(1)-O(3)170.39(10)
C(1)-Sn(1)-O(1)94.65(14)C(13)-Sn(1)-O(3)85.78(14)C(7)-Sn(1)-O(3)84.75(14)
C(13)-Sn(1)-C(7)113.43(17)

Symmetry code A: -x+1, -y+2, -z+1.

Scheme 3: The coordination mode of the tin atoms in compound 1.
Scheme 3:

The coordination mode of the tin atoms in compound 1.

Table 2

X-ray data for some type II diorganotin carboxylates, {[R2Sn(O2CR′)]2O}2.

CompoundaSn(1)-O(1)Sn(1)-O(2)Sn(1)-O(3)Sn(1)-O(5)Sn(2)-O(3)Sn(2)-O(5)Sn(2)-O(5A)
[(n-Bu2SnL1)2O]22.093(5)2.746(6)2.498(5)2.003(4)2.206(4)2.021(4)2.148(4)
[(n-Bu2SnL2)2O]22.121(6)2.746(7)2.517(7)1.993(6)2.191(6)2.047(6)2.171(6)
[(n-Bu2SnL3)2O]22.104(6)2.573(6)2.688(5)2.009(5)2.202(6)2.036(5)2.166(5)
[(n-Bu2SnL4)2O]22.116(4)2.771(4)2.587(4)2.004(3)2.239(4)2.015(3)2.178(3)
[(n-Bu2SnL5)2O]22.124(2)2.682(2)2.647(2)2.044(2)2.234(2)2.011(2)2.171(2)
[(n-Bu2SnL6)2O]22.124(4)2.672(2)2.621(2)2.051(2)2.247(2)2.005(2)2.171(2)
[(n-Bu2SnL)2O]22.155(4)2.675(4)2.422(4)2.032(3)2.243(4)2.036(3)2.140(3)

aL1=4-FC6H4CH2COO (Tiekink et al., 1995); L2=C6H5COCH2CH2COO (Ng et al., 1991); L3=4-NH2C6H4COO (Chandrasekhar et al., 1988); L4=C4H8NCS2CH2COO (Yin et al., 2004); L5=4-(C6H5N=N)-2-(HO)C6H3COO (Baul et al., 2006); L6=4-(4-ClC6H4N=N)-2-(HO)C6H3COO (Baul et al., 2006); L=2-PhC2HN3COO (this work).

Compound 2 crystallizes in the monoclinic space group P21/n, and the tin atom is five-coordinated and possesses a distorted [SnC3O2] trigonal bipyramidal geometry, formed by a monodentate carboxylate group, three cyclohexyl groups and a coordinated ethanol molecule. The axial sites are occupied by the O atoms of the ethanol and carboxylate [O(1)-Sn(1)-O(3) 170.39(10)°], and the trigonal plane is defined by the three cyclohexyl groups with the C-Sn-C angles in the range of 113.43(17)–122.22(17)°. The bond length of the coordinated Sn(1)-O(3) [2.518(3) Å] is significantly longer than that of the covalent Sn(1)-O(1) [2.161(3) Å], so that the Sn(1) atom is displaced out of the C3 trigonal plane of the trans-C3SnO2 trigonal bipyramidal polyhedron in the direction of O(1) by 0.216(2) Å. The Sn-C lengths from 2.145(4) to 2.152(4) Å are similar to those found in other reported five-coordination tricyclohexyltin carboxylates, such as 3-C5H4NCO2Sn(cyclo-C6H11)3(H2O) (Teoh et al., 1999), (4-MeC6H4)3GeCH(C6H4OMe-4)CH2CO2Sn(cyclo-C6H11)3(H2O) (Din et al., 2003) and O(CH2CH2)2NC(O)SCH2CO2Sn(cyclo-C6H11)3(H2O) (Ng, 1996). To the best of our knowledge (CSD version 5.36), this is a first example of structurally characterized tricyclohexyltin carboxylate containing an alcohol coordination to tin. In the crystal, the molecules are linked into a one-dimensional supramolecular chain by the intermolecular hydrogen bond O(3)-H(3)···O(2)i [i: -x+1/2, y+1/2, -z+3/2) (H(3)···O(2) 1.93 Å, O(3)···O(2)i 2.744(4) Å, O(3)-H(3)···O(2)i 160.1°] between the ethanol O-H and carbonyl oxygen atom of carboxylate (Figure 3).

Figure 3: The 1D supramolecular chain of 2 formed by the intermolecular O-H···O hydrogen bonds.
Figure 3:

The 1D supramolecular chain of 2 formed by the intermolecular O-H···O hydrogen bonds.

In vitro cytotoxicity

Under the experimental conditions, the results of the cytotoxic assay of the compounds against HeLa (cervix tumor cell), CoLo 205 (colon carcinoma cell) and MCF-7 (mammary tumor cell) are shown in Table 3. Compounds 1 and 2 displayed the potent in vitro activity, and are more active than clinically used cis-platin. The activity of 2 is better than that of 1, which is consistent with the result that triorganotin compounds are usually more active than the corresponding diorganotin compounds (Hadjikakou and Hadjiliadis, 2009; Amir et al., 2014). In the 0.1% DMSO solution, compound 1 displays the poor anticancer activity due to the high coordination number and steric hindrance around tin, which limit the access of tin to the target (Amir et al., 2014). The activity of 1 is comparable with that of other di-n-butylstannoxanes such as {[n-Bu2(3-FC6H4COO)Sn]2O}2 (MCF-7, IC50 0.496 μg/mL) and {[n-Bu2(2-HO-4- MeOC6H3COO)Sn]2O}2 (MCF-7, IC50 0.131 μg/mL) (Gielen, 2002), but better than that of {[n-Bu2(2-O2NC6H4CH=CHOO)Sn]2O}2 (HeLa, IC50 5.717 μg/mL) (Liu et al., 2011). The activity of 2 is similar to that of our previously reported tricyclohexyltin 2-phenyl-1,2,3-triazole-4-carboxylate (Tian et al., 2005) bis(triorganotin) 2,6-pyridinedicarboxylates (Wang et al., 2014), but is lower than triphenyltin 2-phenyl-1,2, 3-triazole-4-carboxylate (Tian et al., 2005). Gielen et al. found that the di- and triorganotin steroid carboxylates, crown-ethercarboxylates and fluorine-substituted carboxylates exhibited quite potent cytotoxicities against many human tumor cell lines such as MCF-7, EVSAT, WiDr, IGROV, MI9, A498 and H226 (Gielen, 2002; Gielen et al., 2005). The IC50 values of some dibutyl- and triphenyltin derivatives of such ligands against the cell lines were less than 1 ng/mL. Thus, both the organotin moiety and the ligand appear to play an important role in the activity, and further structure modification of organotin compounds is valuable for enhancing cytotoxicity.

Table 3

In vitro cytotoxicity (IC50, μg/mL) of the compounds.

CompoundHeLaCoLo205MCF-7
10.315±0.0541.014±0.0940.266±0.048
20.176±0.0310.423±0.0570.230±0.068
cis-platin1.443±0.3324.611±0.3325.457±0.335

Data represent mean±S.D. All assays were performed in triplicate for three independent experiments.

Conclusion

In summary, two new di-n-butyltin and tricyclohexyltin derivatives of 2-phenyl-1,2,3-triazole-4-carboxylic acid have been synthesized and characterized. The di-n-butyltin complex is a centrosymmetric tetranuclear bis(dicarboxylatotetra-n-butyldistannoxane) having the basic type II structural motif. The tricyclohexyltin complex possesses a trigonal bipyramidal environment with the axial positions occupied by the carboxylate oxygen and hydroxyl oxygen of an ethanol molecule and forms a one-dimensional supramolecular chain by the intermolecular O-H···O hydrogen bonds. The two compounds have good in vitro cytotoxic activity against three human tumor cell lines, i.e. HeLa, CoLo205 and MCF-7, and can be considered as antitumor compounds to further study.

Experimental section

General

2-Phenyl-1,2,3-triazole-4-carboxylic acid was prepared according to the literature procedure (Liu and Cao, 1993). All other chemicals (Sinopharm Chemical Reagent Company Limited, Shanghai, China) were of reagent grade and were used without further purification. Carbon, hydrogen and nitrogen analyses were determined using a Perkin Elmer 2400 Series II elemental analyzer (Perkin Elmer, Waltham, MA, USA). IR spectra were recorded on a Nicolet Nexus 470 FT-IR spectrophotometer using KBr disks in the range 4000–400 cm-1 (Thermo Nicolet Corporation, Madison, WI, USA). 1H and 13C NMR spectral data were collected using a Bruker Avance DMX500 FT-NMR spectrometer with CDCl3 as solvent and tetramethylsilane as internal standard (Bruker Corporation, Switzerland).

Synthesis of the complex {[n-Bu2Sn(OOCC2HN3 Ph-2)]2O}2 (1)

To a suspension of di-n-butyltin oxide (0.50 g, 2 mmol) in 50 mL of anhydrous toluene was added 2-phenyl-1,2,3-triazole-4-carboxylic acid (0.38 g, 2 mmol). The reaction mixtures were heated under reflux for 6 h with a Dean-Stark separator, and then allowed to cool to room temperature. The solution was filtered and the solvent was removed under reduced pressure by a rotary evaporator. The resulting white solid was recrystallized from trichloromethane/methanol (1:1, V/V). Yield 0.59 g (69%), m.p. 170.9–171.4°C. Anal. calcd. for C68H96N12O10Sn4: C 47.58, H 5.64, N 9.79; found C 47.60, H 5.57, N 9.72%. IR (KBr, cm-1): 2955s, 2926s, 2858s, 1626s [ν(COO-)as], 1599s (C=N, triazole ring), 1587s [(ν(COO-)as)], 1497s, 1464m, 1425m, 1388s [ν(COO-)s], 1342s [ν(COO-)s], 1251s, 1139m, 1027m, 966m, 833s, 752s, 640s (Sn-O-Sn). 1H NMR (CDCl3, δ, ppm): 8.24 (2H, s, CH=N), 8.18 (4H, d, J=7.9 Hz, H-2 of phenyl), 7.51 (4H, t, J=7.8 Hz, H-3 of phenyl), 7.38 (2H, t, J=7.3 Hz, H-4 of phenyl), 1.87–1.28 (24H, m, CH2CH2CH2Sn), 0.82 (6H, t, J=7.2 Hz, CH3), 0.77 (6H, t, J=7.2 Hz, CH3). 13C NMR (CDCl3, δ, ppm): 165.3 (C=O), 143.8 (C=N), 139.8 (CH=N), 138.3, 129.8, 128.6, 119.6 (phenyl), 28.8, 28.2 (α-C), 27.9, 27.5 (β-C), 27.4, 27.0 (γ-C), 13.8, 13.8 (δ-C) (n-butyl). 119Sn NMR (CDCl3, δ, ppm): –194.0, –205.2.

Synthesis of the complex (cyclo-C6H11)3Sn(OOCC2HN3Ph-2)(C2H5OH) (2)

To the solution of 2-phenyl-1,2,3-triazole-4-carboxylic acid (0.38 g, 2 mmol) in ethanol (50 mL) was added tricyclohexyltin chloride (0.81 g, 2 mmol) and Et3N (0.20 g, 2 mmol). The mixture was refluxed for 2 h and the solvent was removed by evaporation in vacuo. The crude products were recrystallized from ethanol. Yield 70.5%, m.p. 78–79°C. Anal. calcd. for C29H45N3O3Sn: C 57.82, H 7.53, N 6.98; found C 57.68, H 7.27, N 6.82%. IR (KBr, cm-1): 3446bs (O-H), 2921s, 2846s, 1597 (C=N, triazole ring), 1583 [ν(COO-)as], 1496s, 1446, 1412, 1356, 1342 [ν(COO-)s], 1296m, 1269m, 1171m, 1026m, 992m, 965s, 807m, 794s, 756s, 672s. 1H NMR (CDCl3, δ, ppm): 8.17 (2H, d, J=7.8 Hz, H-2 of phenyl), 8.16 (1H, s, CH=N), 7.49 (2H, t, J=7.9 Hz, H-3 of phenyl), 7.38 (1H, t, J=7.4 Hz, H-4 of phenyl), 3.72 (t, J=7.0 Hz, CH2O), 2.07–1.31 (34H, m, cyclohexyl+OH), 1.24 (3H, t, J=7.0 Hz, CH3). 13C NMR (CDCl3, δ, ppm): 165.3 (C=O), 143.9 (C=N), 139.8 (CH=N), 138.3, 129.7, 128.6, 119.6 (phenyl), 57.9 (CH2O), 34.1 [1J(119Sn-13C)=330 Hz, α-C], 31.4 (β-C), 29.2 [3J(119Sn-13C)=65 Hz, γ-C], 27.2 (δ-C), 18.3 (CH3). 119Sn NMR (CDCl3, δ, ppm): 17.6.

X-ray crystallography

The colorless single crystal of 1 and 2 was obtained from ethanol by slow evaporation at room temperature. Diffraction measurements were performed on a Bruker Smart Apex imaging-plate area detector (Bruker Corporation, Germany) fitted with graphite monochromatized MoKα radiation (0.71073 Å) using the φ and ω scan technique. The structures were solved by direct methods and refined by a full-matrix least-squares procedure based on F2 using SHELXL-97 (Sheldrick, 2008). The non-hydrogen atoms were refined anisotropically and hydrogen atoms were placed at calculated positions in the riding model approximation, with C-H=0.93 Å for aromatic H atoms, C-H=0.96 Å for methyl H atoms, C-H=0.97 Å for methylene H atoms, C-H=0.98 Å for methine H atoms and O-H=0.85 Å for hydroxy H atoms. In complex 1, the n-butyl groups are disordered over two positions, and their site occupancies were refined to 0.64(2):0.36(2) for C(22), 0.50(6):0.50(6) for C(29)-C(30) and 0.51(5):0.49(5) for C(32)-C(34), respectively. In refinements, the C-C bonds and 1,3-distances of the disorderly butyl groups were restrained to 1.53(1) and 2.50(2) Å, respectively. Crystal data, collection procedures and refinement results are shown in Table 4. The crystallographic data of compounds 1 and 2 have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication numbers CCDC 1052854 and 1052855.

Table 4

Crystallographic and refinement data of 1 and 2.

Compound12
Empirical formulaC68H96N12O10Sn4C29H45N3O3Sn
Formula weight1716.33602.37
Crystal systemTriclinicMonoclinic
Space groupP-1P21/n
a (Å)11.1234(10)10.744(4)
b (Å)14.3109(11)14.270(6)
c (Å)14.3898(11)19.662(8)
α (°)114.2040(10)90
β (°)92.938(2)94.168(5)
γ (°)108.8450(10)90
Volume (Å3)1932.0(3)3007(2)
Z14
Dc (g cm-3)1.4751.331
μ (mm-1)1.3380.882
F(000)8681256
Crystal size (mm)0.15×0.12×0.080.22×0.20×0.18
θ range (°)1.59–26.001.76–26.00
Total reflections15 23822 789
Uniq. reflections7519 (Rint=0.0261)5903 (Rint=0.0300)
Reflections with I>2σ(I)53364666
GOF on F21.0091.056
R indices [I>2σ(I)]R=0.0492, wR=0.1217R=0.0426, wR=0.1054
R indices (all data)R=0.0713, wR=0.1365R=0.0573, wR=0.1134
Δρmin, Δρmax (e Å-3)-0.491, 0.694-0.379, 0.919

In vitro cytotoxicity

Cytotoxic activity was assayed against two human tumor cell lines, Hela (cervix tumor cell) and MCF-7 (mammary tumor cell). The samples were prepared by dissolving the test compounds in DMSO (1H NMR shows that the compounds are stable in the solvent DMSO) and by diluting the resultant solutions with water. In the assays, the final concentration of DMSO was less than 0.1% (the concentration used was found to be non-cytotoxic against tumor cells). Cis-platin was purchased from Mayne Pharma Pty Ltd (Australia). The in vitro cytotoxic activity of the compounds was measured by the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay according to the literature (Denizot and Lang, 1986). All cells were cultured in DMEM (Dulbecco’s Modified Eagle Medium) supplemented with 10% heat-inactivated newborn calf serum at 37°C in a humidified 5% CO2 incubator and were seeded into each well of a 96-well plate and were fixed for 24 h. The following day, different concentrations of the test compounds were added. After incubation with various concentrations of test compounds for 72 h, the inhibition on cell proliferation was measured. The dose causing 50% inhibition of cell growth (IC50) was calculated.


Corresponding author: Laijin Tian, Key Laboratory of Natural Products and Pharmaceutical Intermediates, Qufu Normal University, Qufu 273165, China, e-mail:

Acknowledgments

This work was supported by Shandong Provincial Natural Science Foundation, China (ZR2013BM007), and the National Natural Science Foundation of China (21302110).

References

Amir, M. K.; Khan, S.; Rehman, Z.; Shah, A.; Butler, I. S. Anticancer activity of organotin carboxylates. Inorg. Chim. Acta 2014, 423(Part B), 14–25.10.1016/j.ica.2014.07.053Search in Google Scholar

Baul, T. S. B.; Rynjah, W.; Rivarola, E.; Lycka, A.; Holcapek, M.; Jirasko, R.; Vos, D. D.; Butcher, R. J.; Linden, A. Synthesis and characterization of bis(dicarboxylatotetraorganodistannoxane) units involving 5-[(E)-2-(aryl)-1-diazenyl]-2-hydroxybenzoic acids: an investigation of structures by X-ray diffraction, NMR, electrospray ionization MS and assessment of in vitro cytotoxicity. J. Organomet. Chem. 2006, 691, 4850–4862.Search in Google Scholar

Bondi, A. Van der Waals volumes and radii. J. Phys. Chem. 1964, 68, 441–451.Search in Google Scholar

Carraher, C. E.; Roner, M. R. Organotin polymers as anticancer and antiviral agents. J. Organomet. Chem. 2014, 751, 67–82.Search in Google Scholar

Chalupa, J.; Handlir, K.; Cisarova, I.; Jirasko, R.; Brus, J.; Lycka, A.; Ruzicka, A.; Holecek, J. Structural study of bis(triorganotin) esters of 4-ketopimelic acid. J. Organomet. Chem. 2006, 691, 2631–2640.Search in Google Scholar

Chandrasekhar, V.; Day, R. O.; Holmes, J. M.; Holmes, R. R. Mononuclear and tetranuclear diorganotin carboxylates from the reaction of dimethyltin oxide with anthranilic acid and its p-amino isomer. Inorg. Chem. 1988, 27, 958–964.Search in Google Scholar

Chandrasekhar, V.; Nagendran, S.; Baskar, V. Organotin assemblies containing SnO bonds. Coord. Chem. Rev. 2002, 235, 1–52.Search in Google Scholar

Davies, A. G.; Gielen, M.; Pannell, K. H.; Tiekink, E. R. T. Tin Chemistry: Fundamentals, Frontiers, and Applications; John Wiley & Sons: Chichester, UK, 2008.Search in Google Scholar

Davis, A.G. Organotin Chemistry, 2nd Edition; Wiley-VCH: Weinheim, 2004, pp 8–23.Search in Google Scholar

Deacon, G. B.; Phillips, R. J. Relationships between the carbon-oxygen stretching frequencies of carboxylato complexes and the type of carboxylate coordination. Coord. Chem. Rev. 1980, 33, 227–250.Search in Google Scholar

Denizot, F.; Lang, R. Rapid colorimetric assay for cell growth and survival. J. Immunol. Methods 1986, 89, 271–277.10.1016/0022-1759(86)90368-6Search in Google Scholar

Din, I. U.; Molloy, K. C.; Mazhar, M.; Dastgir, S.; Ali, S.; Mahon, M. F. Some tricyclohexyltin carboxylates containing germanium: synthesis, spectral and crystallographic characterization. Appl. Organomet. Chem. 2003, 17, 781–787.Search in Google Scholar

Dong, Y.; Yu, Y.; Tian, L. Synthesis, structural characterization and antibacterial activity of triorganotin ferrocenecarboxylates. Main Group Met. Chem. 2014, 37, 91–95.Search in Google Scholar

Gielen, M. Organotin compounds and their therapeutic potential: a report from the Organometallic Chemistry Department of the Free University of Brussels. Appl. Organometal. Chem. 2002, 16, 481–494.Search in Google Scholar

Gielen, M.; Biesemans, M.; Willem, R. Organotin compounds: from kinetics to stereochemistry and antitumour activities. Appl. Organometal. Chem. 2005, 19, 440–450.Search in Google Scholar

Hadjikakou, S. K.; Hadjiliadis, N. Antiproliferative and anti-tumor activity of organotin compounds. Coord. Chem. Rev. 2009, 253, 235–249.Search in Google Scholar

Holecek, J.; Nadvornik, M.; Handlir, K.; Lycka, A. 13C and 119Sn NMR study of some four- and five-coordinate triphenyltin compounds. J. Organome. Chem. 1983, 241, 177–184.Search in Google Scholar

Holecek, J.; Nadvornik, M.; Handlir, K.; Lycka, A. 13C and 119Sn NMR spectra of di-n-butyltin(IV) compounds. J. Organomet. Chem. 1986, 315, 299–308.Search in Google Scholar

Kaur, H.; Puri, J. K.; Kaur, J.; Dhir, K. Synthesis, spectroscopic and biological studies of diorganotin and triorganotin derivatives of albendazole, ofloxacin and 3-carboxypropyldisulfide. Main Group Met. Chem. 2013, 36, 49–55.Search in Google Scholar

Liu, F.; Cao, L. 2-Phenyl-1,2,3-triazole derivatives. J. Xinjiang Univ. (Nat. Sci. Ed.) 1993, 10, 70–72.Search in Google Scholar

Liu, C.; Liu, S.; Du, D.; Zhu, D.; Xu, L. Organotin(IV) carboxylates of (E)-3-(2-nitrophenyl) propenoic acid: synthesis, spectroscopic characterization, crystal structure and antitumor activity. J. Mol. Struct. 2011, 1003, 134–140.Search in Google Scholar

Mao, W.; Bao, K.; Feng, Y.; Wang, Q.; Li, J.; Fan, Z. Synthesis, crystal structure, and fungicidal activity of triorganotin1-methyl-1H-imidazole-4-carboxylates. Main Group Met. Chem. 2015, 38, 27–30.Search in Google Scholar

Martins, J. C.; Biesemans, M.; Willem, R. Tin NMR based methodologies and their use in structural organotin chemistry. Progr. NMR Spectrosc. 2000, 36, 271–322.Search in Google Scholar

Nadvornik, M.; Holecek, J.; Handlir, K.; Lycka, A. The 13C and 119Sn NMR spectra of some four- and five-coordinate tri-n-butyltin(IV) compounds. J. Organomet. Chem. 1984, 275, 43–51.Search in Google Scholar

Nath, M.; Vats, M.; Roy, P. Tri- and diorganotin complexes of biologically important orotic acid: synthesis, spectroscopic studies, in vitro anti-cancer, DNA fragmentation, enzyme assays and in vivo anti-inflammatory activities. Eur. J. Med. Chem. 2013, 59, 310–321.Search in Google Scholar

Nath, M.; Vats, M.; Roy, P. Design, spectral characterization, anti-tumor and anti-inflammatory activity of triorganotin hydroxycarboxylates, apoptosis inducers: in vitro assessment of induction of apoptosis by enzyme, DNA-fragmentation, acridine orange and comet assays. Inorg. Chim. Acta 2014, 423, 70–82.Search in Google Scholar

Ng, S. W. Water-coordinated triorganotin carboxylates. Crystal structures of bis(triphenyltin 3-oxapentamethylenethiocarbamoylacetate) hydrate. Main Group Met. Chem. 1996, 19, 113–120.Search in Google Scholar

Ng, S. W.; Wei, C.; Kumar Das, V. G. Crystal structure of the tetrabutylbis(3-benzoylpropionato)distannoxane dimer. J. Organomet. Chem. 1991, 412, 39–45.Search in Google Scholar

Seter, M.; Dakternieks, D.; Duthie, A. Chiral rings from BINOL dicarboxylic acids and alkane ditin linkers. Main Group Met. Chem. 2012, 35, 73–80.Search in Google Scholar

Shang, X.; Meng, X.; Alegria, E. C. B. A.; Li, Q.; Guedes Da Silva, M. F. C.; Kuznetsov, M. L.; Pombeiro, A. J. L. Syntheses, molecular structures, electrochemical behavior, theoretical study, and antitumor activities of organotin complexes containing 1-(4-chlorophenyl)-1-cyclopentanecarboxylato ligands. Inorg. Chem. 2011, 50, 8158–8167.Search in Google Scholar

Sheldrick, G. M. A short history of SHELX. Acta Crystallogr. 2008, A64, 112–122.Search in Google Scholar

Szorcsik, A.; Nagy, L.; Sletten, J.; Szalontai, G.; Kamu, E.; Fiore, T.; Pellerito, L.; Kalman, E. Preparation and structural studies on dibutyltin(IV) complexes with pyridine mono- and dicarboxylic acids. J. Organome. Chem. 2004, 689, 1145–1154.Search in Google Scholar

Teoh, S.-G.; Tan, D.-S.; Yeap, G.-Y.; Fun, H.-K. Tricyclohexyltin complexes with picolinic, nicotinic and 5-bromonicotinic acids. J. Coord. Chem. 1999, 48, 53–61.Search in Google Scholar

Tian, L.; Cao, H.; Wang, S.; Sun, Y.; Liu, Z. Synthesis, characterization and cytotoxic activity of tricyclohexyltin carboxylates derived from cyclic dicarboxylic anhydrides. J. Coord. Chem. 2013, 66, 624–637.Search in Google Scholar

Tian, L.; Sun, Y.; Li, H.; Zheng, X.; Cheng, Y.; Liu, X.; Qian, B. Synthesis, characterization and biological activity of triorganotin 2-phenyl-1,2,3-triazole- 4-carboxylates. J. Inorg. Biochem. 2005, 99, 1646–1652.Search in Google Scholar

Tiekink, E. R. T. Structural chemistry of organotin carboxylates: a review of the crystallographic literature. Appl. Organomet. Chem. 1991, 5, 1–25.Search in Google Scholar

Tiekink, E. R. T. The rich diversity in tin carboxylate structures. Trends Organomet. Chem. 1994, 1, 71–116.Search in Google Scholar

Tiekink, E. R. T.; Gielen, M.; Bouhdid, A.; Biesemans, M.; Willem, R. Crystal structure of the dimeric bis(p-fluoro- and pentafluorophenylacetato)tetra-n-butyldistannoxanes. J. Organomet. Chem. 1995, 494, 247–253.Search in Google Scholar

Wang, X.; Liu, X.; Tian, L. Synthesis, characterization and in vitro cytotoxic activity of bis(triorganotin) 2,6-pyridinedicarboxylates. Main Group Met. Chem. 2014, 37, 143–147.Search in Google Scholar

Willem, R.; Verbruggen, I.; Gielen, M.; Biesemans, M.; Mahieu, B.; Baul, T. S. B.; Tiekink, E. R. T. Correlating Mössbauer and solution- and solid-state 117Sn NMR data with X-ray diffraction structural data of triorganotin 2-[(E)-2-(2-hydroxy-5-methylphenyl)-1-diazenyl]benzoates. Organometallics 1998, 17, 5758–5766.Search in Google Scholar

Yin, H.-D.; Xue, S.-C.; Wang, Q.-B. Syntheses, characterization and crystal structure of the dimeric organotin compound: {[n-Bu2Sn(O2CCH2S2CNC4H8)]2O}2. Chinese J. Inorg. Chem. 2004, 20, 421–425.Search in Google Scholar

Received: 2015-3-25
Accepted: 2015-7-10
Published Online: 2015-8-8
Published in Print: 2015-8-1

©2015 by De Gruyter

This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/mgmc-2015-0010/html
Scroll to top button